跳至主要内容
临床试验/PACTR202205750416982
PACTR202205750416982已完成1 期

Tranexamic acid versus etamsylate in reducing blood loss during normal vaginal delivery in patients with high risk of postpartum hemorrhage: Randomized controlled trial

October 6th university and Ain shams Maternity hospital0 个研究点目标入组 180 人开始时间: 2022年5月9日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • All pregnant women who will give birth vaginally, full term of gestation age, susceptible for post-partum hemorrhage as: • History of pervious postpartum hemorrhage
  • precipitate labour or instrumental delivery or
  • prolonged induction of labour.
  • Anemic (hemoglobin between 8-10mg/dl),
  • diabetic, macrosomic baby

排除标准

  • Women with thrombophilia, or coagulopathy cardiovascular, renal, or liver disorders; or contraindication to any drug used in the study protocol as (allergy to TXA or its excipients)

研究者

发起方
October 6th university and Ain shams Maternity hospital

相似试验